Reflex human papillomavirus testing: Leave the cytology interpretation alone

Cancer

Volumn 99, Issue 4, 2003, Pages 187-190

  Davey, Diane D ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ATYPICAL SQUAMOUS CELL OF UNDETERMINED SIGNIFICANCE; CANCER CYTODIAGNOSIS; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; CYTOLOGY; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MODEL; MULTICENTER STUDY; NONHUMAN; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; REVIEW; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COST-BENEFIT ANALYSIS; DNA, VIRAL; EPITHELIAL CELLS; FEMALE; HUMANS; MODELS, STATISTICAL; OBSERVER VARIATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATIENT CARE PLANNING; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINES; REPRODUCIBILITY OF RESULTS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0041471307     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11508     Document Type: Review

References (16)

1. Levi AW, Kelly DP, Rosenthal DL, Ronnett BM. Atypical squamous cells (of undetermined significance) in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods. Cancer (Cancer Cytopathol). 2003;99:191-197.
2. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120-2129.
3. Solomon D, Davey DD, Kurman R, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
4. Raab SS. Human papillomavirus reporting: impact on Bethesda cytology reports. Arch Pathol Lab Med. In press.
5. Kurman RJ, Solomon D. The Bethesda system for reporting cervical/vaginal cytologic diagnoses. New York: Springer-Verlag, 1994.
6. Stoler MH, Schiffman M, for the ALTS Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285:1500-1505.
7. Solomon D, Schiffman M, Tarone R, for the ALTS Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299.
8. Cox JT, Schiffman M, Solomon D, for the ALTS Group. Prospective follow-up suggests similar risk of subsequent CIN 2 or 3 among women with CIN 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. In press.
9. Clavel C, Masure M, Bory J-P, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer. 2001; 89:1616-1623.
10. Kulasingam SI, Hughes JP, Kiviat NB, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002;288:1749-1757.
11. http://www.fda.gov//bbs/topics/NEWS/2003/NEW00890.html [accessed Mar 31, 2003.]
12. An HJ, Cho NH, Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer. 2003;97:1672-1680.
13. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52:342-362.
14. Lorincz AT, Richart RM. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med. In press.
15. Austin RM. Follow-up of abnormal gynecologic cytology: a College of American Pathologists Q-Probe study of 16,312 cases from 306 laboratories. Arch Pathol Lab Med. 2000;124: 1113-1114.
16. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA. 2002;287:2382-2390.